Abstract:Short-chain fatty acids (SCFAs) including acetate, formate, propionate, and butyrate are the end products of dietary fiber and host glycan fermentation by the human gut microbiota (HGM). SCFAs produced in the column are of utmost importance for host physiology and health. Butyrate and propionate improve gut health and play a key role in the neuroendocrine and immune systems. Prediction of HGM metabolic potential is important for understanding the influence of diet and HGM-produced metabolites on human health. … Show more
“…The Paraclostridium genus is characterized to produce butyrate through the degradation of lysine and succinate, similar to Lachnoclostridium . [ 66 ] The mechanisms and community dynamics that promote expansion of Paraclostridium during 2ʹFL fermentation and Lachnoclostridium during DFL fermentation are unclear as they both appear to expand into the butyrate‐producing niche left vacated by E. hallii .…”
Scope: Fucosylated human milk oligosaccharides (fHMOs) are metabolized by Bifidobacterium infantis and promote syntrophic interactions between microbiota that colonize the infant gut. The role of fHMO structure on syntrophic interactions and net microbiome function is not yet fully understood. Methods and results: Metabolite production and microbial populations are tracked during mono-and co-culture fermentations of 2ʹfucosyllactose (2ʹFL) and difucosyllactose (DFL) by two B. infantis strains and Eubacterium hallii. This is also conducted in an in vitro modeled microbiome supplemented by B. infantis and/or E. hallii. Metabolites are quantified by high performance liquid chromatography. Total B. infantis and E. hallii populations are quantified through qRT-PCR and community composition through 16S amplicon sequencing. Differential metabolism of 2ʹFL and DFL by B. infantis strains gives rise to strain-and fHMO structure-specific syntrophy with E. hallii. Within the modeled microbial community, fHMO structure does not strongly alter metabolite production in aggregate, potentially due to functional redundancy within the modeled community. In contrast, community composition is dependent on fHMO structure. Conclusion: Whereas short chain fatty acid production is not significantly altered by the specific fHMO structure introduced to the modeled community, specific fHMO structure influences the composition of the gut microbiome.
“…The Paraclostridium genus is characterized to produce butyrate through the degradation of lysine and succinate, similar to Lachnoclostridium . [ 66 ] The mechanisms and community dynamics that promote expansion of Paraclostridium during 2ʹFL fermentation and Lachnoclostridium during DFL fermentation are unclear as they both appear to expand into the butyrate‐producing niche left vacated by E. hallii .…”
Scope: Fucosylated human milk oligosaccharides (fHMOs) are metabolized by Bifidobacterium infantis and promote syntrophic interactions between microbiota that colonize the infant gut. The role of fHMO structure on syntrophic interactions and net microbiome function is not yet fully understood. Methods and results: Metabolite production and microbial populations are tracked during mono-and co-culture fermentations of 2ʹfucosyllactose (2ʹFL) and difucosyllactose (DFL) by two B. infantis strains and Eubacterium hallii. This is also conducted in an in vitro modeled microbiome supplemented by B. infantis and/or E. hallii. Metabolites are quantified by high performance liquid chromatography. Total B. infantis and E. hallii populations are quantified through qRT-PCR and community composition through 16S amplicon sequencing. Differential metabolism of 2ʹFL and DFL by B. infantis strains gives rise to strain-and fHMO structure-specific syntrophy with E. hallii. Within the modeled microbial community, fHMO structure does not strongly alter metabolite production in aggregate, potentially due to functional redundancy within the modeled community. In contrast, community composition is dependent on fHMO structure. Conclusion: Whereas short chain fatty acid production is not significantly altered by the specific fHMO structure introduced to the modeled community, specific fHMO structure influences the composition of the gut microbiome.
“…To predict the metabolic potential of microbial taxa identified via 16S rRNA enumeration, we used a subsystem-based approach implemented in the microbial community of SEED, an application of the SEED genomic platform [23] as we have described previously [14]. Curated across human gut microbial genomes, metabolic subsystems include biochemical pathways classified into two categories: (i) the biosynthesis of vitamins, amino acids, and cofactors [24,25], and (ii) production of SCFAs [26]. To analyze the glycosyl hydrolase (GH) and polysaccharide lyase (PL) gene family abundance in profiled taxa, we obtained the distribution of carbohydrate active enzymes (CAZymes) in the analyzed reference genomes using the dbCAN2 tool [25] and observed the production of SCFAs.…”
Section: Methodsmentioning
confidence: 99%
“…For example, Bifidobacterium predominantly generates lactate, whereas Bacteroides predominantly generate propionate. We used genome reconstruction using 2865 gut reference genomes [26] to identify taxa with the coding potential to generate major fermentation products. We previously reported herb-induced alterations of SCFAs [19], and so the focus here is on prebiotic fibers (Figure 4).…”
Section: Prebiotic Restructuring Of Community Fermentation Pathwaysmentioning
Several studies have examined the impact of prebiotics on gut microbiota and associated changes in host physiology. Here, we used the in vitro cultivation of human fecal samples stimulated with a series of chemically related prebiotics and medicinal herbs commonly used in Ayurvedic medicine, followed by 16S rRNA sequencing. We applied a genome-wide metabolic reconstruction of enumerated communities to compare and contrast the structural and functional impact of prebiotics and medicinal herbs. In doings so, we examined the relationships between discrete variations in sugar composition and sugar linkages associated with each prebiotic to drive changes in microbiota composition. The restructuring of microbial communities with glycan substrates alters community metabolism and its potential impact on host physiology. We analyzed sugar fermentation pathways and products predicted to be formed and prebiotic-induced changes in vitamin and amino acid biosynthesis and degradation. These results highlight the utility of combining a genome-wide metabolic reconstruction methodology with 16S rRNA sequence-based community profiles to provide insights pertaining to community metabolism. This process also provides a rational means for prioritizing in vivo analysis of prebiotics and medicinal herbs in vivo to test hypotheses related to therapeutic potential in specific diseases of interest.
“…For acetate, we considered six possible synthesis pathways, including the WL pathway and a recently discovered pathway involving succinyl-CoA:acetate CoA-transferase and succinyl-CoA synthetase [52, 87, 88]. Meanwhile, for butyrate and propionate, we explored four and three possible synthetic pathways, respectively [89, 90] (refer to Supplementary Table S15 for details). We assembled a reference catalog of gene products for each pathway, resulting in 4563 AA sequences for acetate pathways, 2744 for butyrate pathways, and 415 for propionate pathways.…”
Immunotherapy has proven to be a boon for patients grappling with metastatic melanoma, significantly enhancing their clinical condition and overall quality of life. A compelling connection was discovered between the composition of the intestinal microbiome and the effectiveness of immunotherapy substantiated in both animal models and human patients. Nonetheless, the precise biological mechanisms through which gut microbes influence melanoma treatment outcomes remain poorly understood. This study conducted a high-resolution metagenomic meta-analysis, employing cutting-edge bioinformatics techniques including genome-resolved metagenomics, strain profiling, comparative genomics, and metabolic reconstruction. According to the obtained results, the systemic metabolic depletion of the gut microbiome causes a lack of response to immunotherapy. Specifically, the presence of bacteria adept at utilizing polysaccharides, as well as those responsible for cobalamin, amino acids, and fatty acids production, decreased in patients who experienced unfavorable treatment outcomes. In contrast, patients who had successful outcomes after immunotherapy exhibited a prevalence of amino acids and cobalamin prototrophs, while autotrophy in these substances characterized the microbiomes of patients with unsuccessful outcomes. The metabolic reconstruction of short-chain fatty acid biosynthesis pathways did not differentiate bacteria linked to treatment outcomes based on their ability to produce acetate, butyrate, or propionate. However, the cobalamin-dependent Wood-Ljungdahl pathway of acetate synthesis was directly associated with immunotherapy effectiveness.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.